Enzymatica publ AB

ST:ENZY Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$47.60 Million

Skr534.02 Million SEK

Market Cap Rank

#25281 Global

#318 in Sweden

Share Price

Skr2.20

Change (1 day)

-3.51%

52-Week Range

Skr1.65 - Skr4.84

All Time High

Skr770.83

Enzymatica publ AB - Asset Resilience Ratio

Latest as of September 2025: 22.17%

Enzymatica publ AB (ENZY) has an Asset Resilience Ratio of 22.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr33.08 Million

Cash + Short-term Investments

Total Assets

Skr149.24 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Enzymatica publ AB's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Enzymatica publ AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr33.08 Million	22.17%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr33.08 Million	22.17%

Asset Resilience Insights

Good Liquidity Position: Enzymatica publ AB maintains a healthy 22.17% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.